Prepubertal chronic stress and ketamine administration to rats as a neurodevelopmental model of schizophrenia

Edward Ram1, Shani Raphaeli, Avi Avital

  • 1Division of General Surgery, Hasharon Hospital Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Israel.

Insights

Chronic stress and ketamine exposure in young rats mimic schizophrenia symptoms. This preclinical model reveals deficits in motor activity, anhedonia, and cognitive impairments, offering insights into the disorder.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Animal Models

Background:

  • Schizophrenia vulnerability is linked to stress and early-life N-methyl-D-aspartate (NMDA) receptor dysfunction.
  • NMDA receptor alterations during central nervous system development can lead to psychosis and cognitive deficits.

Purpose of the Study:

  • To investigate the behavioral effects of chronic stress and ketamine administration during a critical developmental window in male rats.
  • To establish a novel animal model for schizophrenia-like symptoms.

Main Methods:

  • Male rats were exposed to chronic stress (postnatal days 30-60) and/or ketamine (postnatal days 41-45).
  • Behavioral assessments included locomotor activity, sucrose preference test (anhedonia), object recognition, eight-arm radial maze (learning), and prepulse inhibition (PPI).

Main Results:

  • Ketamine and ketamine+stress groups showed increased locomotor activity; stress-only group showed decreased activity.
  • Anhedonia (decreased sucrose intake) was observed in stress and ketamine+stress groups.
  • Ketamine+stress group exhibited impaired object recognition, learning, and prepulse inhibition.

Conclusions:

  • Combined prepubertal chronic stress and ketamine administration create a valid animal model for schizophrenia-like symptoms.
  • This model highlights the impact of early-life stress and NMDA receptor modulation on neurodevelopmental psychiatric disorders.

Related Concept Videos